Nery Pablo B, Thornhill Rebecca, Nair Girish M, Pena Elena, Redpath Calum J
aDivision of Cardiology, Department of Medicine, University of Ottawa Heart Institute bDepartment of Medical Imaging, The Ottawa Hospital cDepartment of Radiology, University of Ottawa, Ottawa, Ontario, Canada.
Curr Opin Cardiol. 2017 Jan;32(1):1-9. doi: 10.1097/HCO.0000000000000349.
Percutaneous catheter ablation can be an effective treatment for paroxysmal atrial fibrillation. However, catheter ablation for the treatment of persistent atrial fibrillation or long-standing persistent atrial fibrillation is associated with success rates of 45-50% at 1 year. To address the challenge of ablating patients with persistent atrial fibrillation, several approaches have been proposed. Atrial scar-based catheter ablation is a promising strategy for ablation of persistent atrial fibrillation.
In this review, we outline the role of atrial scar/fibrosis in the pathophysiology of atrial fibrillation and how this encouraged clinical studies assessing the atrial substrate using scar-based mapping. We highlight current approaches to voltage mapping of atrial scar in patients with atrial fibrillation. The characteristics, techniques, and outcomes of recently published studies evaluating scar-based catheter ablation strategies for the treatment of atrial fibrillation are discussed. Finally, we explore the role of noninvasive tools such as delayed enhancement MRI to assess the atrial fibrillation substrate.
In summary, the optimal catheter ablation strategy for persistent atrial fibrillation remains unknown. Current data highlight the need for a better understanding of the substrate and mechanisms of arrhythmia maintenance in this population. Atrial scar-based catheter ablation has recently emerged as a promising strategy for ablation of atrial fibrillation. However, the available data have limitations that preclude definitive conclusions regarding the utility of this strategy. Further research is needed to assess the role of scar-based ablation for persistent atrial fibrillation.
经皮导管消融术可有效治疗阵发性心房颤动。然而,用于治疗持续性心房颤动或长期持续性心房颤动的导管消融术在1年时的成功率为45%-50%。为应对消融持续性心房颤动患者的挑战,已提出了几种方法。基于心房瘢痕的导管消融术是消融持续性心房颤动的一种有前景的策略。
在本综述中,我们概述了心房瘢痕/纤维化在心房颤动病理生理学中的作用,以及这如何推动了使用基于瘢痕的标测评估心房基质的临床研究。我们重点介绍了心房颤动患者中心房瘢痕电压标测的当前方法。讨论了最近发表的评估基于瘢痕的导管消融策略治疗心房颤动的研究的特点、技术和结果。最后,我们探讨了诸如延迟强化磁共振成像等非侵入性工具在评估心房颤动基质中的作用。
总之,持续性心房颤动的最佳导管消融策略仍然未知。当前数据凸显了更好地了解该人群中心律失常维持的基质和机制的必要性。基于心房瘢痕的导管消融术最近已成为消融心房颤动的一种有前景的策略。然而,现有数据存在局限性,无法就该策略的效用得出明确结论。需要进一步研究来评估基于瘢痕的消融术对持续性心房颤动的作用。